Medartis Holding AG (SWX:MED)

Market Cap	902.63M -3.2%
Revenue (ttm)	269.26M +19.8%
Net Income	8.35M +136.7%
EPS	0.67 +139.3%
Shares Out	12.43M
PE Ratio	108.36
Forward PE	50.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,710
Open	71.50
Previous Close	72.60
Day's Range	71.50 - 74.10
52-Week Range	71.50 - 97.50
Beta	1.20
Analysts	Buy
Price Target	95.97 (+29.51%)
Earnings Date	Aug 18, 2026

About Medartis Holding AG

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 1,337
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: MED

Financial Performance

In 2025, Medartis Holding AG's revenue was 269.26 million, an increase of 19.76% compared to the previous year's 224.83 million. Earnings were 8.35 million, an increase of 136.65%.